Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Label Reconciliation during Dispensing – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Label Reconciliation during Dispensing – V 2.0

Standard Operating Procedure for Label Reconciliation during Dispensing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/108/2025
Supersedes SOP/SIM/108/2022
Page No. Page 1 of 10
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To define the procedure for reconciliation of labels used during the dispensing of materials for sterile injectable manufacturing to prevent label mismatch, mix-ups, and ensure GMP compliance.

2. Scope

This SOP is applicable to all labeling activities carried out in the dispensing areas related

to sterile injectable materials, including APIs and excipients.

3. Responsibilities

  • Dispensing Operator: Responsible for labeling all dispensed containers correctly and returning unused labels.
  • QA Officer: Responsible for verification and reconciliation of labels post-dispensing.
  • Production Supervisor: To ensure adherence to label reconciliation steps.
See also  Sterile Injection Manufacturing: SOP for Documentation of Packaging Line Performance - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for implementation and compliance of this SOP.

5. Procedure

5.1 Label Generation

  • Labels are generated from the approved batch record or ERP system.
  • Each label shall include Material Name, Batch No., Quantity, Dispensed By, Date, and Status.

5.2 Label Application

  • Labels shall be affixed to each dispensed container immediately after weighing.
  • Partial quantities in different containers shall be labeled with ‘Part 1 of X’, ‘Part 2 of X’, etc.

5.3 Reconciliation Process

  1. At the end of the dispensing process, all unused labels must be returned to QA.
  2. QA must count:
    • Total labels printed
    • Total labels used
    • Total labels returned
  3. Any discrepancy must be investigated and documented in the Label Reconciliation Form (Annexure-1).
See also  Sterile Injectable Manufacturing: SOP for Segregating Finished Injectable Products by Batch - V 2.0

5.4 Label Destruction

Unused and damaged labels shall be destroyed in the presence of QA personnel and recorded in the Destruction Logbook (Annexure-2).

5.5 Label Storage and Traceability

  • Used labels shall remain on dispensed containers through manufacturing stages.
  • Reconciliation records must be attached to the Batch Manufacturing Record.

6. Abbreviations

  • QA: Quality Assurance
  • ERP: Enterprise Resource Planning
  • SOP: Standard Operating Procedure

7. Documents

  1. Label Reconciliation Form – Annexure-1
  2. Label Destruction Logbook – Annexure-2

8. References

  • EU GMP Guidelines – Chapter 5 and Annex 1
  • Company Quality Manual

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Dispensing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance
See also  Manufacturing: SOP for Documentation of In-Process Observations - V 2.0

11. Annexures

Annexure-1: Label Reconciliation Form

Batch No. Material Labels Printed Used Returned Destroyed Verified By
INJ-235 Lactose 6 4 2 2 S. Mishra

Annexure-2: Label Destruction Logbook

Record of destroyed labels including reason, method, date, and witness signature.

Revision History

Revision Date Revision No. Details Reason Approved By
05/01/2022 1.0 Initial issue New SOP QA Head
18/06/2025 2.0 Added destruction log requirement Regulatory Compliance QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Aerosol: SOP for Propellant Compatibility Testing with Container Materials – V 2.0
Next Post: Gel Manufacturing: SOP for Verification of Cleaning Effectiveness of Gel Equipment – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version